These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

747 related articles for article (PubMed ID: 32890749)

  • 1. Microfluidic organ-on-a-chip models of human liver tissue.
    Moradi E; Jalili-Firoozinezhad S; Solati-Hashjin M
    Acta Biomater; 2020 Oct; 116():67-83. PubMed ID: 32890749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modeling the Human Body on Microfluidic Chips.
    Jalili-Firoozinezhad S; Miranda CC; Cabral JMS
    Trends Biotechnol; 2021 Aug; 39(8):838-852. PubMed ID: 33581889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microengineered Organ-on-a-chip Platforms towards Personalized Medicine.
    Kankala RK; Wang SB; Chen AZ
    Curr Pharm Des; 2018; 24(45):5354-5366. PubMed ID: 30799783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Construction of in vitro liver-on-a-chip models and application progress.
    Liu J; Du Y; Xiao X; Tan D; He Y; Qin L
    Biomed Eng Online; 2024 Mar; 23(1):33. PubMed ID: 38491482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. From organ-on-chip to body-on-chip: The next generation of microfluidics platforms for in vitro drug efficacy and toxicity testing.
    Lacombe J; Soldevila M; Zenhausern F
    Prog Mol Biol Transl Sci; 2022; 187(1):41-91. PubMed ID: 35094781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cultivating human tissues and organs over lab-on-a-chip models: Recent progress and applications.
    Bhagat S; Singh S
    Prog Mol Biol Transl Sci; 2022; 187(1):205-240. PubMed ID: 35094775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver microphysiological platforms for drug metabolism applications.
    Kulsharova G; Kurmangaliyeva A
    Cell Prolif; 2021 Sep; 54(9):e13099. PubMed ID: 34291515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrating Biosensors in Organs-on-Chip Devices: A Perspective on Current Strategies to Monitor Microphysiological Systems.
    Ferrari E; Palma C; Vesentini S; Occhetta P; Rasponi M
    Biosensors (Basel); 2020 Aug; 10(9):. PubMed ID: 32872228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microfluidics in High-Throughput Drug Screening: Organ-on-a-Chip and
    Yoon S; Kilicarslan You D; Jeong U; Lee M; Kim E; Jeon TJ; Kim SM
    Biosensors (Basel); 2024 Jan; 14(1):. PubMed ID: 38275308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Organ-on-a-chip: future of female reproductive pathophysiological models.
    Deng ZM; Dai FF; Wang RQ; Deng HB; Yin TL; Cheng YX; Chen GT
    J Nanobiotechnology; 2024 Jul; 22(1):455. PubMed ID: 39085921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An integrated biomimetic array chip for establishment of collagen-based 3D primary human hepatocyte model for prediction of clinical drug-induced liver injury.
    Xiao RR; Lv T; Tu X; Li P; Wang T; Dong H; Tu P; Ai X
    Biotechnol Bioeng; 2021 Dec; 118(12):4687-4698. PubMed ID: 34478150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Bioprinted Liver-on-a-Chip for Drug Screening Applications.
    Knowlton S; Tasoglu S
    Trends Biotechnol; 2016 Sep; 34(9):681-682. PubMed ID: 27291461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Next generation human skin constructs as advanced tools for drug development.
    Abaci HE; Guo Z; Doucet Y; Jacków J; Christiano A
    Exp Biol Med (Maywood); 2017 Nov; 242(17):1657-1668. PubMed ID: 28592171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microfluidics and Organ-on-a-Chip for Disease Modeling and Drug Screening.
    Nasiri R; Zhu Y; de Barros NR
    Biosensors (Basel); 2024 Feb; 14(2):. PubMed ID: 38392005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver 'organ on a chip'.
    Beckwitt CH; Clark AM; Wheeler S; Taylor DL; Stolz DB; Griffith L; Wells A
    Exp Cell Res; 2018 Feb; 363(1):15-25. PubMed ID: 29291400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heart-on-a-chip platforms and biosensor integration for disease modeling and phenotypic drug screening.
    Criscione J; Rezaei Z; Hernandez Cantu CM; Murphy S; Shin SR; Kim DH
    Biosens Bioelectron; 2023 Jan; 220():114840. PubMed ID: 36402101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro platforms for evaluating liver toxicity.
    Bale SS; Vernetti L; Senutovitch N; Jindal R; Hegde M; Gough A; McCarty WJ; Bakan A; Bhushan A; Shun TY; Golberg I; DeBiasio R; Usta BO; Taylor DL; Yarmush ML
    Exp Biol Med (Maywood); 2014 Sep; 239(9):1180-1191. PubMed ID: 24764241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microfluidic 'brain-on chip' systems to supplement neurological practice: development, applications and considerations.
    Jarrah R; Nathani KR; Bhandarkar S; Ezeudu CS; Nguyen RT; Amare A; Aljameey UA; Jarrah SI; Bhandarkar AR; Fiani B
    Regen Med; 2023 May; 18(5):413-423. PubMed ID: 37125510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Co-Culture of Human Primary Hepatocytes and Nonparenchymal Liver Cells in the Emulate® Liver-Chip for the Study of Drug-Induced Liver Injury.
    Shi Q; Arefin A; Ren L; Papineau KS; Barnette DA; Schnackenberg LK; Hawes JJ; Avigan M; Mendrick DL; Ewart L; Ronxhi J
    Curr Protoc; 2022 Jul; 2(7):e478. PubMed ID: 35790095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human microphysiological models of airway and alveolar epithelia.
    Lagowala DA; Kwon S; Sidhaye VK; Kim DH
    Am J Physiol Lung Cell Mol Physiol; 2021 Dec; 321(6):L1072-L1088. PubMed ID: 34612064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.